Diabetes Core Update cover image

Special Edition: Time in Range: Medication Management – March 2023

Diabetes Core Update

00:00

The Power of GLP Ones for Weight Loss

Herzepitide is a dual GLP one GIP receptor agonist. People with obesity without diabetes, that group achieved 22% weight loss. The power of these agents for weight management is pretty amazing.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app